COVID-19 pathophysiology: A review
By Koichi Yuki, M. Fujiogi, S. Koutsogiannaki. Clinical Immunology, 2020
1,874 citations recorded by the source corpus.
In December 2019, a novel coronavirus, now named as SARS-CoV-2, caused a series of acute atypical respiratory diseases in Wuhan, Hubei Province, China. The disease caused by this virus was termed COVID-19. The virus is transmittable between humans and has caused pandemic worldwide. The number of death tolls continues to rise and a large number of countries have been forced to do social distancing and lockdown. Lack of targeted therapy continues to be a problem. Epidemiological studies showed that elder patients were more susceptible to severe diseases, while children tend to have milder symptoms. Here we reviewed the current knowledge about this disease and considered the potential explanation of the different symptomatology between children and adults.
Subfields: Infectious Diseases, Neurology
View Paper: https://www.semanticscholar.org/paper/b6c8120652213aa2b77bc38b28a90f62273df4d0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- E. Huang
- F. Zhou
- O. Chang
- C. Y. Wong
- Jiawen Deng
- Q. Zuo
- W. Hou
- Z. Silver
Citations in the corpus
- The prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients: a meta‐analysis (2020, methodology): “The data extraction form included the following items: (1) author names, (2) study title, (3) publication date, (4) digital object identifier, (5) country of origin, (6) study design, (7) sample size, (8) questionnaire response rate, (9) patient demographics (i.”